The drug distributor reported an 11% increase in revenue, driven by strong growth in its U.S. pharmaceutical segment.
- McKesson shareholders reaped a 52% return, including dividends, in 2022. That gain was owed in part to shareholders’ growing confidence in the company’s outlook in the wake of a February 2022 legal settlement that resolved several lawsuits against McKesson for its alleged role in facilitating the overprescription of opioids. The company said it continued to dispute those allegations.
- In March 2023, McKesson announced a five-year medical equipment and supply contract with the U.S. Department of Veterans Affairs.
Courtesy of McKesson
Company Information
As of 6/5/23
Country/Territory
U.S.
Headquarters
Irving, Texas
Industry
Wholesalers: Health Care
CEO
Brian S. Tyler
Website
Company Type
Public
Ticker
MCK
Revenues ($M)
$263,966
Profits ($M)
$1,114
Market Value ($M)
$48,757
Employees
66,500
Figures are for fiscal year ended March 31, 2022. Market value as of March 31, 2023.
Key Financials (Last Fiscal Year)
$ millions
% change
Revenues ($M)
$263,966
10.8%
Profits ($M)
$1,114
-
Assets ($M)
$63,298
-
Total Stockholder Equity ($M)
$-2,272
-
Profit Ratios
Profit as % of Revenues
0.4%
Profits as % of Assets
1.8%
Profits as % of Stockholder Equity
-
Earnings Per Share (Last Fiscal Year)
Earnings Per Share ($)
7.23
EPS % Change (from 2021)
-
EPS % Change (5 year annual rate)
-20.5%
EPS % Change (10 year annual rate)
2.6%
Total Return
Total Return to Investors (2022)
51.9%
Total Return to Investors (5 year, annualized)
20.4%
Total Return to Investors (10 year, annualized)
15.4%
McKesson Rank History
Historical Data
Year | Revenues ($M) | Profits ($M) | Assets ($M) | Total Stockholder Equity ($M) |
---|---|---|---|---|
2022 | $238,2283.1% | $-4,539-604.3% | $65,015 | $-21 |
2021 | $231,0517.8% | $9002547.1% | $61,247 | $5,092 |
2020 | $214,3192.9% | $34-49.3% | $59,672 | $8,094 |
2019 | $208,3574.9% | $67-98.7% | $60,381 | $9,804 |
2018 | $198,5333.1% | $5,070124.5% | $60,969 | $11,095 |
SHOW MORE
Lists ranking McKesson
Latest news for McKesson